165 related articles for article (PubMed ID: 35900077)
1. Acute kidney injury after Pfizer COVID-19 vaccine due to crescentic fibrillary glomerulonephritis.
Al-Sawalmeh K; Pandes M; Niño JA; Avila-Casado C
Clin Nephrol; 2022 Oct; 98(4):205-208. PubMed ID: 35900077
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin-Negative DNAJB9-Associated Fibrillary Glomerulonephritis: A Report of 9 Cases.
Said SM; Rocha AB; Royal V; Valeri AM; Larsen CP; Theis JD; Vrana JA; McPhail ED; Bandi L; Safabakhsh S; Barnes C; Cornell LD; Fidler ME; Alexander MP; Leung N; Nasr SH
Am J Kidney Dis; 2021 Mar; 77(3):454-458. PubMed ID: 32711071
[TBL] [Abstract][Full Text] [Related]
3. Fibrillary glomerulonephritis or complement 3 glomerulopathy: a rare case of diffuse necrotising crescentic glomerulonephritis with C3-dominant glomerular deposition and positive DNAJB9.
Baker LW; Khan M; Cortese C; Aslam N
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33602773
[TBL] [Abstract][Full Text] [Related]
4. Fibrillary glomerulonephritis masquerading as rapidly progressive glomerulonephritis with pseudo-linear glomerular basement membrane staining.
El-Husseini A; Aycinena JC; George B; Jennings S; Cornea V; Sawaya BP
Clin Nephrol; 2015 Oct; 84(4):231-5. PubMed ID: 26249548
[TBL] [Abstract][Full Text] [Related]
5. Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis.
Shah HH; Thakkar J; Pullman JM; Mathew AT
Indian J Nephrol; 2017; 27(2):157-160. PubMed ID: 28356674
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker.
Liang S; Chen D; Liang D; Xu F; Zhang M; Yang F; Zhu X; Li P; Zeng C
J Nephrol; 2021 Jun; 34(3):883-892. PubMed ID: 32557205
[TBL] [Abstract][Full Text] [Related]
7. DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN.
Dasari S; Alexander MP; Vrana JA; Theis JD; Mills JR; Negron V; Sethi S; Dispenzieri A; Highsmith WE; Nasr SH; Kurtin PJ
J Am Soc Nephrol; 2018 Jan; 29(1):51-56. PubMed ID: 29097623
[TBL] [Abstract][Full Text] [Related]
8. Rapidly progressive IgA nephropathy with membranoproliferative glomerulonephritis-like lesions in an elderly man following the third dose of an mRNA COVID-19 vaccine: a case report.
Morimoto N; Mori T; Shioji S; Taguchi T; Watanabe H; Sakai K; Mori K; Yamamura A; Hanioka A; Akagi Y; Fujiki T; Mandai S; Mori Y; Ando F; Susa K; Iimori S; Naito S; Sohara E; Ohashi K; Uchida S
BMC Nephrol; 2023 Apr; 24(1):108. PubMed ID: 37095451
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of DNAJB9-Positive Fibrillary Glomerulonephritis After Kidney Transplantation: A Case Series.
El Ters M; Bobart SA; Cornell LD; Leung N; Bentall A; Sethi S; Fidler M; Grande J; Hernandez LH; Cosio FG; Zand L; Amer H; Fervenza FC; Nasr SH; Alexander MP
Am J Kidney Dis; 2020 Oct; 76(4):500-510. PubMed ID: 32414663
[TBL] [Abstract][Full Text] [Related]
10. A case of juvenile-onset fibrillary glomerulonephritis diagnosed by mass spectrometry and immunohistochemistry of DNAJB9.
Hattori K; Shimizu R; Tanaka S; Terashima T; Hiramatsu M; Shimomura T; Ito T; Morinaga T; Terasaki M; Shimizu A; Morozumi K; Tamai H
CEN Case Rep; 2022 Nov; 11(4):412-416. PubMed ID: 35199316
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients.
Nasr SH; Dasari S; Lieske JC; Benson LM; Vanderboom PM; Holtz-Heppelmann CJ; Giesen CD; Snyder MR; Erickson SB; Fervenza FC; Leung N; Kurtin PJ; Alexander MP
Kidney Int; 2019 May; 95(5):1269-1272. PubMed ID: 31010480
[TBL] [Abstract][Full Text] [Related]
12. Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9).
Klomjit N; Alexander MP; Zand L
Kidney360; 2020 Sep; 1(9):1002-1013. PubMed ID: 35369552
[TBL] [Abstract][Full Text] [Related]
13. A child with crescentic glomerulonephritis following SARS-CoV-2 mRNA (Pfizer-BioNTech) vaccination.
Kim S; Jung J; Cho H; Lee J; Go H; Lee JH
Pediatr Nephrol; 2023 Jan; 38(1):299-302. PubMed ID: 35854121
[TBL] [Abstract][Full Text] [Related]
14. IgA-dominant glomerulonephritis with DNAJB9-negative fibrillar polytypic immunoglobulin deposits in the subepithelium.
Muto R; Maeda K; Fukui S; Saito S; Kato N; Kosugi T; Shimizu A; Maruyama S
CEN Case Rep; 2023 Aug; 12(3):323-328. PubMed ID: 36576710
[TBL] [Abstract][Full Text] [Related]
15. Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis in a young female: a case study.
Singh PP; Krishna A; Sharma A; Kumar O
Ultrastruct Pathol; 2020 Nov; 44(4-6):501-504. PubMed ID: 32657244
[TBL] [Abstract][Full Text] [Related]
16. DNAJB9 Fibrillary Glomerulonephritis With Membranous-Like Pattern: A Case-Based Literature Review.
Sabanis N; Liaveri P; Geladari V; Liapis G; Moustakas G
Cureus; 2023 Oct; 15(10):e47862. PubMed ID: 37899889
[TBL] [Abstract][Full Text] [Related]
17. DNA J homolog subfamily B member 9 and other advances in fibrillary glomerulonephritis.
Andeen NK; Avasare RS
Curr Opin Nephrol Hypertens; 2021 May; 30(3):294-302. PubMed ID: 33767057
[TBL] [Abstract][Full Text] [Related]
18. Complete remission of DnaJ homolog subfamily B member 9-positive fibrillary glomerulonephritis following steroid monotherapy in an elderly Japanese woman.
Uchida T; Komatsu S; Sakai T; Kojima A; Iwama S; Sugisaki K; Oda T
CEN Case Rep; 2021 Aug; 10(3):442-447. PubMed ID: 33656648
[TBL] [Abstract][Full Text] [Related]
19. Rapidly progressive glomerulonephritis due to coexistent anti-glomerular basement membrane disease and fibrillary glomerulonephritis.
Cheungpasitporn W; Zacharek CC; Fervenza FC; Cornell LD; Sethi S; Herrera Hernandez LP; Nasr SH; Alexander MP
Clin Kidney J; 2016 Feb; 9(1):97-101. PubMed ID: 26798468
[TBL] [Abstract][Full Text] [Related]
20. A case of mistaken identity: fibrillary glomerulonephritis masquerading as crescentic anti-glomerular basement membrane disease.
Thomas JA; Vasin D; Lin M; Anderson AE; Alpers CE
Clin Nephrol; 2016 Feb; 85(2):114-20. PubMed ID: 26636330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
